CD8A and neoplasm: B16F10-OVA cells were thus subcutaneously implanted into the flanks of B6 and E2-/- mice and 15 days later splenic, CFSE-labeled OT-I CD8+​ ​T cells were injected directly into the tumor (Figure 3C).